Name |
Topic |
Location |
Date |
|---|---|---|---|
1st Meeting |
Formation of Consortium |
Roche, Basel, Switzerland |
July 5 2005 |
2nd Meeting |
Distribution of work, budget |
Sanofi-Aventis, Frankfurt, Germany |
October 5 2005 |
Ad hoc Meeting |
Compound selection |
November Altana AG, Hamburg, Germany |
November 28 2006 |
3rd Meeting |
Kick-off |
Schering AG, Berlin, Germany |
January 17 2006 |
4th Meeting |
Start of in vivo studies |
Novartis, Basel, Switzerland |
April 7 2006 |
Work package 3.4 Meeting |
Database - User interface |
Genedata, Basel, Switzerland |
May 5 2006 |
Work package 3.5 Meeting |
Mechanistic Investigations |
University of Wuerzburg |
July 18 2006 |
5th Meeting |
Update - Technical Details |
Univ College of Dublin, Ireland |
October 10-11 2006 |
6th Meeting |
Results of in vivo studies |
Merck-Serono, Ivrea, Italy |
March 5-6 2007 |
WP 3.5 Meeting |
Mechanistic Investigations |
University of Wuerzburg (D) |
May 31, 2007 |
7th Meeting |
Toxigogenomics Results |
Boehringer-Ingelheim, Biberach (D) |
July 9-10, 2007 |
8th Meeting |
Proteomics/Metabonomics Results |
Sanofi-Aventis, Chilly-Mazarin (F) |
October 1-2, 2007 |
Integrated analysis per study |
J&J, Antwerp (B) |
January 14-15, 2008 |